Spero Therapeutics, Inc. (FRA:2HA)

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $5.44M USD in the quarter ending September 30, 2025, a decrease of -59.60%. This brings the company's revenue in the last twelve months to $40.55M, down -61.91% year-over-year. In the year 2024, Spero Therapeutics had annual revenue of $47.98M, down -53.77%.

• Revenue (ttm): $40.55M
• Revenue Growth: -61.91%
• P/S Ratio: 3.17
• Revenue / Employee: $1.27M
• Employees: 32
• Market Cap: 109.45M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.98M	-55.80M	-53.77%
Dec 31, 2023	103.78M	50.27M	93.95%
Dec 31, 2022	53.51M	35.25M	193.10%
Dec 31, 2021	18.26M	8.93M	95.67%
Dec 31, 2020	9.33M	-8.82M	-48.59%